Remidio

Remidio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Today, the human eye is unlocking early insights into systemic health, and Remidio is at the forefront of this transformation. Remidio is a pioneer in AI-driven eye care, leading the shift from care of the eye to healthcare through the eye. As the first company to receive CDSCO approval in India for our adaptive ophthalmic AI, in addition to CE marking in Europe under Class II EU-MDR, we are redefining how diseases like diabetic retinopathy, glaucoma, and AMD are detected early, in close to patient contexts, while remaining confident of extending this to systemic disease detection such as CVD, CKD and liver diseases, in the future. With CE-marked, FDA 510(k)-registered devices, our solutions have screened 16 million+ patients across 40+ countries, integrating teleophthalmology and AI for fast, accurate diagnoses. Our innovative retinal imaging solutions ensure precision and efficiency in clinical workflows. Our journey began humbly - thanks to the chance meeting of our founder, with a mission driven ophthalmologist, who brought into focus the need for decentralizing eye testing with simple to use and affordable devices. That conversation, 15 years back, sparked a vision to make high-quality preventive care accessible to all. Guided by innovation, empathy, and a commitment to global impact, our journey is just beginning !
Looking for a particular Remidio employee's phone or email?

Remidio Questions

News

Q&A: AI software offers cost-effective DR screening without internet access - Healio

Q&A: AI software offers cost-effective DR screening without internet access Healio

Health-tech innovator Remidio achieves unprecedented scale in the US with its revolutionary retinal solutions - PR Newswire

Health-tech innovator Remidio achieves unprecedented scale in the US with its revolutionary retinal solutions PR Newswire

ICYMI: Smartphone-based fundus camera provides option for glaucoma screening - Ophthalmology Times

ICYMI: Smartphone-based fundus camera provides option for glaucoma screening Ophthalmology Times

Kerala Govt, Remidio launch Nayanamritham 2.0, an AI-assisted chronic eye disease screening programme - Express Healthcare

Kerala Govt, Remidio launch Nayanamritham 2.0, an AI-assisted chronic eye disease screening programme Express Healthcare

Path-breaking Study Reports High Sensitivity in Diabetic Retinopathy Screening Using Smartphones and Automated-AI in Primary-Care: Remidio Innovative Solutions - PR Newswire APAC - 美通社

Path-breaking Study Reports High Sensitivity in Diabetic Retinopathy Screening Using Smartphones and Automated-AI in Primary-Care: Remidio Innovative Solutions - PR Newswire APAC 美通社

Validation of a simple-to-use, affordable, portable, wavefront aberrometry-based auto refractometer in the adult population: A prospective study - BMC Ophthalmology

Validation of a simple-to-use, affordable, portable, wavefront aberrometry-based auto refractometer in the adult population: A prospective study BMC Ophthalmology

Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class - Times of India

Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class Times of India

Remidio Inc to launch Instaref R20, a handheld portable auto refractometer, at the American Academy of Ophthalmology 2022 - PR Newswire

Remidio Inc to launch Instaref R20, a handheld portable auto refractometer, at the American Academy of Ophthalmology 2022 PR Newswire

Innovative Smartphone-based Retinal Camera Outperforms Expensive Table-top System in Detecting Diabetic Retinopathy in a Two-year Study - PR Newswire UK

Innovative Smartphone-based Retinal Camera Outperforms Expensive Table-top System in Detecting Diabetic Retinopathy in a Two-year Study PR Newswire UK

Remidio Innovative Solutions: A startup providing cure for retinopathy - The Economic Times

Remidio Innovative Solutions: A startup providing cure for retinopathy The Economic Times

India brings early Diabetic Retinopathy detection to the last mile with Artificial Intelligence - Business Standard

India brings early Diabetic Retinopathy detection to the last mile with Artificial Intelligence Business Standard

Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval - PR Newswire

Remidio's Revolutionary AI on a smartphone for Referable Diabetic Retinopathy (DR) Receives EU MDR Class II Regulatory Approval PR Newswire

Smartphone-based Remidio Fundus-On-Phone Camera, Developed by Remidio Innovative Solutions, Outperforms Traditional Table-top System in Detecting Diabetic Retinopathy - PR Newswire

Smartphone-based Remidio Fundus-On-Phone Camera, Developed by Remidio Innovative Solutions, Outperforms Traditional Table-top System in Detecting Diabetic Retinopathy PR Newswire

Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive and Early Detection of Retinopathy - PR Newswire

Smartphone-based Retinal Imaging Together With Artificial Intelligence Powers Automated, Sensitive and Early Detection of Retinopathy PR Newswire

Indigenously Developed Smartphone-based Retinal Imaging Device Powers Automated, Sensitive and Early Detection of Diabetic Retinopathy: Study in Nature Eye Journal - PR Newswire

Indigenously Developed Smartphone-based Retinal Imaging Device Powers Automated, Sensitive and Early Detection of Diabetic Retinopathy: Study in Nature Eye Journal PR Newswire

Top Remidio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant